111 related articles for article (PubMed ID: 21740955)
1. Mechanism of stereoselective interaction between butyrylcholinesterase and ethopropazine enantiomers.
Sinko G; Kovarik Z; Reiner E; Simeon-Rudolf V; Stojan J
Biochimie; 2011 Oct; 93(10):1797-807. PubMed ID: 21740955
[TBL] [Abstract][Full Text] [Related]
2. Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.
Golicnik M; Sinko G; Simeon-Rudolf V; Grubic Z; Stojan J
Arch Biochem Biophys; 2002 Feb; 398(1):23-31. PubMed ID: 11811945
[TBL] [Abstract][Full Text] [Related]
3. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
Bosak A; Gazić I; Vinković V; Kovarik Z
Chem Biol Interact; 2008 Sep; 175(1-3):192-5. PubMed ID: 18582854
[TBL] [Abstract][Full Text] [Related]
5. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.
Masson P; Froment MT; Gillon E; Nachon F; Lockridge O; Schopfer LM
FEBS J; 2008 May; 275(10):2617-31. PubMed ID: 18422653
[TBL] [Abstract][Full Text] [Related]
7. Peripheral site and acyl pocket define selective inhibition of mouse butyrylcholinesterase by two biscarbamates.
Bosak A; Smilović IG; Stimac A; Vinković V; Sinko G; Kovarik Z
Arch Biochem Biophys; 2013 Jan; 529(2):140-5. PubMed ID: 23219600
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates.
Pistolozzi M; Du H; Wei H; Tan W
Drug Metab Dispos; 2015 Mar; 43(3):344-52. PubMed ID: 25504505
[TBL] [Abstract][Full Text] [Related]
9. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
10. Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics.
Masson P; Schopfer LM; Froment MT; Debouzy JC; Nachon F; Gillon E; Lockridge O; Hrabovska A; Goldstein BN
Chem Biol Interact; 2005 Dec; 157-158():143-52. PubMed ID: 16256969
[TBL] [Abstract][Full Text] [Related]
11. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
Katalinić M; Rusak G; Domaćinović Barović J; Sinko G; Jelić D; Antolović R; Kovarik Z
Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
[TBL] [Abstract][Full Text] [Related]
12. Separation, conformation in solution and absolute configuration of ethopropazine enantiomers.
Sinko G; Novak P; Ziher D; Vinković V; Sunjić V; Simeon-Rudolf V
Enantiomer; 2002; 7(2-3):149-56. PubMed ID: 12108633
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
14. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo- and endo-2-norbornyl-N-n-butylcarbamates.
Chiou SY; Huang CF; Yeh SJ; Chen IR; Lin G
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):13-20. PubMed ID: 20030505
[TBL] [Abstract][Full Text] [Related]
16. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
[TBL] [Abstract][Full Text] [Related]
17. Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.
Zhan CG; Zheng F; Landry DW
J Am Chem Soc; 2003 Mar; 125(9):2462-74. PubMed ID: 12603134
[TBL] [Abstract][Full Text] [Related]
18. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
19. The structure of G117H mutant of butyrylcholinesterase: nerve agents scavenger.
Amitay M; Shurki A
Proteins; 2009 Nov; 77(2):370-7. PubMed ID: 19452557
[TBL] [Abstract][Full Text] [Related]
20. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.
Doorn JA; Schall M; Gage DA; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):73-80. PubMed ID: 11601883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
